NEW YORK, N.Y.—June 4, 2007
Also at the dinner, Richard S. Fuld Jr. will be honored in recognition of his leadership in business. Mr. Fuld has been chairman of the Board of Directors of Lehman Brothers Holdings Inc. and Lehman Brothers Inc. since 1994 and chief executive officer of the Company since 1993. He is chairman of Lehman Brothers’ Executive Committee.
Dr. Salvati has dedicated his professional career to the care of thousands of patients, to the education and surgical training of hundreds of residents and fellows and to the improvement of hip surgery. His work has encompassed basic, applied, clinical and biomechanical research to refine the complex aspects of total hip replacement. Notable contributions include measures to reduce the risk of complications and the role of genetic predispositions. For this work he has received several honors, including four American Hip Society Awards, the Nicholas Andry Award of the American Association of Bone and Joint Surgeons and the Lifetime Achievement Award of the Arthritis Foundation.
“For the past 38 years, Dr. Salvati has been an integral member of the HSS family and has greatly contributed not only to the hip and knee service at the hospital, but overall to the fields of orthopedic surgery and musculoskeletal research,” said Louis A. Shapiro, president and chief executive officer of Hospital for Special Surgery. “We are deeply grateful for his service to our hospital and proud to bestow this lifetime achievement award as a way to recognize his passion and commitment to patient care, education and research.”
“It’s been incredibly rewarding to work at HSS,” said Dr. Salvati. “I feel I have a second family in my colleagues, residents and fellows.”
Continuously serving in leadership roles, Dr. Salvati has been at the forefront of major advances in the international field of joint arthroplasty. He served as Chief of the Hip Service for sixteen years and went on to direct the Hip and Knee Service at the hospital. He is a professor of Clinical Orthopedic Surgery at the Weill Cornell Medical College, a past president of the American Hip Society, a past Secretary-Treasurer of the International Hip Society, an Honorary Professor at the University of Buenos Aires, an honorary member of several orthopedic societies, and a reviewer and editorial board member of the most renowned orthopedic journals. His contributions in orthopedics are evidenced by more than 300 peer-reviewed scientific articles and book chapters. As a long-standing recognition for his work, Hospital for Special Surgery has established a Chair in his name.
Richard S. Fuld, Jr., who is also being honored, serves on the Board of Directors of the Federal Reserve Bank of New York and is a member of the Executive Committee of the Board of Directors of The Partnership for New York City. He is also a member of the International Business Council of the World Economic Forum and The Business Council.
In addition, he serves on the Board of Trustees of NewYork-Presbyterian Hospital, Middlebury College and on the Board of Directors of the Robin Hood Foundation.
Mr. Fuld received a bachelor of arts degree from the University of Colorado and an M.B.A. from the New York University Stern School of Business.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.